Zhejiang Medical University, Harvard Medical School and United Biotechnology Co. build joint „Molecular Biotherapy Research Center“ inside Zhejiang University of Traditional Chinese Medicine

The 400 m2 laboratory will be led by Professor Guoping SHI of Harvard Medical School and focus on applications of regulatory T cell technology, e. g., for the treatment of lupus, organ transplantation and cancer.

China Bio news release, April 14, 2016

Zhejiang Medical University, Harvard Medical School and United Biotechnology Co. build joint „Molecular Biotherapy Research Center“ inside Zhejiang University of Traditional Chinese Medicine
Scroll to top